Ville K. Äijälä , Päivi Sirniö , Hanna Elomaa , Henna Karjalainen , Meeri Kastinen , Vilja V. Tapiainen , Maarit Ahtiainen , Olli Helminen , Erkki-Ville Wirta , Jukka Rintala , Sanna Meriläinen , Juha Saarnio , Tero Rautio , Toni T. Seppälä , Jan Böhm , Jukka-Pekka Mecklin , Anne Tuomisto , Markus J. Mäkinen , Juha P. Väyrynen
{"title":"Significance of mucin-suspended tumor bud-like structures in colorectal cancer","authors":"Ville K. Äijälä , Päivi Sirniö , Hanna Elomaa , Henna Karjalainen , Meeri Kastinen , Vilja V. Tapiainen , Maarit Ahtiainen , Olli Helminen , Erkki-Ville Wirta , Jukka Rintala , Sanna Meriläinen , Juha Saarnio , Tero Rautio , Toni T. Seppälä , Jan Böhm , Jukka-Pekka Mecklin , Anne Tuomisto , Markus J. Mäkinen , Juha P. Väyrynen","doi":"10.1016/j.humpath.2025.105772","DOIUrl":null,"url":null,"abstract":"<div><div>Tumor budding (TB) is an independent predictor of adverse prognosis in colorectal cancer (CRC), defined as clusters of fewer than 5 tumor cells at the invasive margin of cancer. According to the international consensus criteria (ITBCC), TB should be evaluated from the non-mucinous regions. However, some tumors also contain tumor bud-like structures within extracellular mucin pools, and the prognostic impact of these structures remains unclear. To assess this, we defined a modified tumor budding variable (TB-Muc), representing the highest number of tumor buds/bud-like structures observed in a hotspot (0.785 mm<sup>2</sup>) at the invasive margin, including extracellular mucin regions. We analyzed the prognostic significance of TB (ITBCC criteria) and TB-Muc in two CRC cohorts (N = 1876). TB-ITBCC was associated with advanced stage and lymphovascular invasion (p < 0.001) but also with shorter cancer-specific survival independent of other prognostic factors (Cohort 1: HR for high vs. low 1.99, 95 % CI 1.32–3.01, p<sub>trend</sub> = 0.0007; Cohort 2: HR 1.35, 95 % CI 0.98–1.85, p<sub>trend</sub> = 0.037). TB-Muc had a comparable independent association with shorter cancer-specific survival (Cohort 1: HR for high vs. low 1.77, 95 % CI 1.18–2.65, p<sub>trend</sub> = 0.006; Cohort 2: HR 1.39, 95 % CI 1.02–1.89, p<sub>trend</sub> = 0.019). Our results indicate that tumor bud-like structures in mucin do not provide additional prognostic value and should not be included in TB evaluation.</div></div>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":"158 ","pages":"Article 105772"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0046817725000590","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Tumor budding (TB) is an independent predictor of adverse prognosis in colorectal cancer (CRC), defined as clusters of fewer than 5 tumor cells at the invasive margin of cancer. According to the international consensus criteria (ITBCC), TB should be evaluated from the non-mucinous regions. However, some tumors also contain tumor bud-like structures within extracellular mucin pools, and the prognostic impact of these structures remains unclear. To assess this, we defined a modified tumor budding variable (TB-Muc), representing the highest number of tumor buds/bud-like structures observed in a hotspot (0.785 mm2) at the invasive margin, including extracellular mucin regions. We analyzed the prognostic significance of TB (ITBCC criteria) and TB-Muc in two CRC cohorts (N = 1876). TB-ITBCC was associated with advanced stage and lymphovascular invasion (p < 0.001) but also with shorter cancer-specific survival independent of other prognostic factors (Cohort 1: HR for high vs. low 1.99, 95 % CI 1.32–3.01, ptrend = 0.0007; Cohort 2: HR 1.35, 95 % CI 0.98–1.85, ptrend = 0.037). TB-Muc had a comparable independent association with shorter cancer-specific survival (Cohort 1: HR for high vs. low 1.77, 95 % CI 1.18–2.65, ptrend = 0.006; Cohort 2: HR 1.39, 95 % CI 1.02–1.89, ptrend = 0.019). Our results indicate that tumor bud-like structures in mucin do not provide additional prognostic value and should not be included in TB evaluation.
期刊介绍:
Human Pathology is designed to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to the understanding of human diseases. Papers published concern morphologic and clinicopathologic observations, reviews of diseases, analyses of problems in pathology, significant collections of case material and advances in concepts or techniques of value in the analysis and diagnosis of disease. Theoretical and experimental pathology and molecular biology pertinent to human disease are included. This critical journal is well illustrated with exceptional reproductions of photomicrographs and microscopic anatomy.